Cripto-1 enhances migration and branching morphogenesis of mouse mammary epithelial cells
- PMID: 11339828
- DOI: 10.1006/excr.2001.5195
Cripto-1 enhances migration and branching morphogenesis of mouse mammary epithelial cells
Abstract
Cripto-1 is an EGF-CFC protein that performs an important role during early vertebrate development and is overexpressed in several types of human cancer. In the present study mouse EpH4, NMuMG, and TAC-2 mammary epithelial cells that are negative for endogenous cripto-1 expression were transfected with the murine cripto-1 cDNA. Cripto-1-transfected cell lines exhibited functional and physiological differences from the original cell lines including enhanced anchorage-independent growth in soft agar (EpH4 cells), growth in serum-free medium, increased proliferation, and formation of branching, duct-like structures when grown in a three-dimensional collagen type I matrix. Furthermore, cripto-1-expressing cell lines showed elevated migration in vitro in Boyden chamber and wound-healing assays. These results indicate that cripto-1 can function through an autocrine pathway that enables mammary epithelial cells to undergo an epithelial to mesenchymal transition.
Similar articles
-
Netrin-1 regulates invasion and migration of mouse mammary epithelial cells overexpressing Cripto-1 in vitro and in vivo.J Cell Sci. 2005 Oct 15;118(Pt 20):4633-43. doi: 10.1242/jcs.02574. Epub 2005 Sep 21. J Cell Sci. 2005. PMID: 16176936
-
Detection and localization of Cripto-1 binding in mouse mammary epithelial cells and in the mouse mammary gland using an immunoglobulin-cripto-1 fusion protein.J Cell Physiol. 2002 Jan;190(1):74-82. doi: 10.1002/jcp.10037. J Cell Physiol. 2002. PMID: 11807813
-
ESX induces transformation and functional epithelial to mesenchymal transition in MCF-12A mammary epithelial cells.Oncogene. 2004 Mar 4;23(9):1766-79. doi: 10.1038/sj.onc.1207391. Oncogene. 2004. PMID: 14767472
-
Cripto: a novel epidermal growth factor (EGF)-related peptide in mammary gland development and neoplasia.Bioessays. 1999 Jan;21(1):61-70. doi: 10.1002/(SICI)1521-1878(199901)21:1<61::AID-BIES8>3.0.CO;2-H. Bioessays. 1999. PMID: 10070255 Review.
-
Cripto-1: an oncofetal gene with many faces.Curr Top Dev Biol. 2005;67:85-133. doi: 10.1016/S0070-2153(05)67003-2. Curr Top Dev Biol. 2005. PMID: 15949532 Review.
Cited by
-
Cripto-1 vaccination elicits protective immunity against metastatic melanoma.Oncoimmunology. 2016 Jan 8;5(5):e1128613. doi: 10.1080/2162402X.2015.1128613. eCollection 2016 May. Oncoimmunology. 2016. PMID: 27467944 Free PMC article.
-
Whence CRIPTO: The Reemergence of an Oncofetal Factor in 'Wounds' That Fail to Heal.Int J Mol Sci. 2021 Sep 21;22(18):10164. doi: 10.3390/ijms221810164. Int J Mol Sci. 2021. PMID: 34576327 Free PMC article. Review.
-
A Novel Localization in Human Large Extracellular Vesicles for the EGF-CFC Founder Member CRIPTO and Its Biological and Therapeutic Implications.Cancers (Basel). 2022 Jul 29;14(15):3700. doi: 10.3390/cancers14153700. Cancers (Basel). 2022. PMID: 35954365 Free PMC article.
-
Nodal and Cripto-1: embryonic pattern formation genes involved in mammary gland development and tumorigenesis.J Mammary Gland Biol Neoplasia. 2004 Apr;9(2):133-44. doi: 10.1023/B:JOMG.0000037158.91940.1c. J Mammary Gland Biol Neoplasia. 2004. PMID: 15300009 Review.
-
Activation of a Nodal-independent signaling pathway by Cripto-1 mutants with impaired activation of a Nodal-dependent signaling pathway.FEBS Lett. 2008 Dec 10;582(29):3997-4002. doi: 10.1016/j.febslet.2008.10.052. Epub 2008 Nov 18. FEBS Lett. 2008. PMID: 19013461 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources